Safety & Feasibility of the ELIOS System in POAG Patients

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02679482` - Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma	N/A
Completed	`NCT05181046` - Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients	N/A
Completed	`NCT01999348` - A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
Completed	`NCT04149899` - Safety and IOP-Lowering Effects of WB007	Phase 1/Phase 2
Not yet recruiting	`NCT04007276` - The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients	Phase 4
Completed	`NCT01814761` - A Study of Bimatoprost 0.01% in the Clinical Setting	Phase 4
Active, not recruiting	`NCT04899063` - Excimer Laser Trabeculostomy Glaucoma Treatment Study	N/A
Completed	`NCT05474716` - The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA	Phase 4
Recruiting	`NCT03067415` - Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily	Phase 2
Not yet recruiting	`NCT06053307` - Treating Psychosocial Distress in Glaucoma	N/A
Terminated	`NCT02858284` - Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension	N/A
Completed	`NCT02796560` - Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension	Phase 4
Recruiting	`NCT05370287` - Adaptive Optics Retinal Imaging	N/A
Not yet recruiting	`NCT05673954` - Glaucoma Assessment Via Reading Ability
Active, not recruiting	`NCT03318510` - LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma	N/A
Active, not recruiting	`NCT03151577` - Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent	N/A
Completed	`NCT04465864` - Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert	Phase 4
Recruiting	`NCT03675412` - Caffeine Consumption in Glaucoma Patients and Healthy Subjects	N/A
Completed	`NCT01833741` - A Study of LUMIGAN® RC in the Clinical Setting	Phase 4
Completed	`NCT03800589` - Assessment of Effectiveness Ex-Press Surgery Modification	N/A

NCT number	NCT05999006
Study type	Interventional
Source	Elios Vision, Inc.
Contact	Rupali Nangia
Phone	714-227-6151
Email	rupali@eliosvision.com
Status	Recruiting
Phase	N/A
Start date	October 18, 2023
Completion date	October 2025

Safety and Feasibility of the ELIOS System in POAG Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms